A Picture of Clinical Trial Supply Asia
In a recent survey published by Pharma IQ, we learnt that 62% of repsondents think China and India hold the most potential for clinical trials in the next 5 years. This along with the result, that over 70% believe they will be outsourcing some element of clinical trials to the BRIC region in the next year, demonsatrate that we can expect much growth in Clinical Trials in Asia in the coming future
About Asia Resource Centre
Providing up-to-date content that offers both relevant information and knowledge on Asia in the pharmaceutical space, is the main driver behind the Asia Focus Centre. Asia is the world's largest and most populated continenant and is at the epicentre of most pharmaceutical companies' strategies.
Tags: Clinical Trial Supply Asia | CRO | Asia | China | India | Europe | US | CTS Infographic | BRIC region | CTS
To receive the white paper on this topic please submit your information in the form below.
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
-
Contributor: Deepa Arora -
Contributor: Bryan Camoens -
Contributor: Jack Wong -
Contributor: Bruce Xue -
Contributor: Pharma IQ -
Contributor: Pharma IQ
-
Contributor: Andrea Charles




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!